Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9138) , 1407-1412
- https://doi.org/10.1016/s0140-6736(98)03085-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1997
- Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.Journal of Clinical Oncology, 1997
- Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancerBritish Journal of Surgery, 1995
- Protracted venous infusion 5-fluorouracil and interferon-α in advanced and refractory colorectal cancerAnnals of Oncology, 1994
- Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinomaAnnals of Oncology, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Continuous systemic 5‐fluorouracil infusion in advanced colorectal cancer: Results in 91 patientsJournal of Surgical Oncology, 1989
- Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvementCancer, 1989
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982